An antisense oligonucleotide against SOD1 delivered intrathecally for patients with SOD1 familial amyotrophic lateral sclerosis: a phase 1, randomised, first-in-man study (Q37015657)
Jump to navigation
Jump to search
scientific article published on 29 March 2013
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | An antisense oligonucleotide against SOD1 delivered intrathecally for patients with SOD1 familial amyotrophic lateral sclerosis: a phase 1, randomised, first-in-man study |
scientific article published on 29 March 2013 |
Statements
1 reference
An antisense oligonucleotide against SOD1 delivered intrathecally for patients with SOD1 familial amyotrophic lateral sclerosis: a phase 1, randomised, first-in-man study (English)
1 reference
Merit E Cudkowicz
1 reference
Stanley H Appel
1 reference
Timothy M Miller
1 reference
Alan Pestronk
1 reference
William David
1 reference
Jeffrey Rothstein
1 reference
Ericka Simpson
1 reference
Patricia L Andres
1 reference
Katy Mahoney
1 reference
Peggy Allred
1 reference
Katie Alexander
1 reference
Lyle W Ostrow
1 reference
David Schoenfeld
1 reference
Daniel A Norris
1 reference
Georgios Manousakis
1 reference
Matthew Crisp
1 reference
Richard Smith
1 reference
C Frank Bennett
1 reference
Kathie M Bishop
1 reference
29 March 2013
1 reference
1 reference
435-442
1 reference
Identifiers
1 reference
1 reference
1 reference